OMNIA · Orchestrating Multi-Omic Nanomedicine Insights with AI and Spatial Biology–Driven Innovation and Training for Hard-to-Treat Cancers
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2026-09-01 → 2030-08-31
- EU contribution
- €1,803,600
- Participants
- 23
- Scheme
- HORIZON-TMA-MSCA-SE
Lines connect the coordinator with its partners.
Project objective
OMNIA is a European-led, globally connected research and training programme redefining how nanotherapeutics are designed and translated for hard-to-treat cancers. By integrating spatial multi-omics, advanced tumor models, and interpretable AI, OMNIA uncovers how nanoparticles interact with the tumor microenvironment—turning complex molecular data into actionable design rules for safer, more effective treatments.Through a harmonized nanoparticle platform, standardized SOPs, and FAIR-compliant data pipelines, OMNIA transforms fragmented nanomedicine studies into a reproducible, data-driven field. Its consortium of leading academic, clinical, and industrial partners from Europe, North America, and Asia bridges expertise in materials science, oncology, and AI to deliver open spatial atlases, validated analysis tools, and regulatory-ready templates.At its core, OMNIA is also a training ecosystem. Over 80 researchers will engage in structured, cross-sector secondments—“capsule curricula” that combine hands-on experimentation, AI analysis, and translational science. This approach cultivates a new generation of scientists fluent in materials–biology–AI integration and capable of driving Europe’s next wave of cancer nanomedicine.Organized into five interconnected work packages spanning nanoparticle design, characterization, spatial biology, AI, and ethics, OMNIA combines scientific excellence, industrial innovation, and mobility-driven collaboration—laying the foundation for a sustainable, spatially informed, AI-enabled future in nanomedicine.
Original text from CORDIS.
Participants
- ANKARA UNIVERSITESI · Tandogan AnkaraCoordinatorTürkiye
- Augusta University Research Institute, Inc. · AugustaUnited States
- BLUEPHARMA - INDUSTRIA FARMACEUTICASA · CoimbraPortugal
- CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD · LyonFrance
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisFrance
- CSD HEALTH CARE · KYIVUkraine
- DREXEL UNIVERSITY · PhiladelphiaUnited States
- FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA · BELLATERRA (BARCELONA)Spain
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisFrance
- Khalifa University of Science and Technology · Abu DhabiUnited Arab Emirates
- LATVIJAS UNIVERSITATE · RIGALatvia
- MATERIALS RESEARCH CENTER · KievUkraine
- PUSAN NATIONAL UNIVERSITY · BUSANSouth Korea
- THE UNIVERSITY OF BIRMINGHAM · BirminghamUnited Kingdom
- THE UNIVERSITY OF MANITOBA · ManitobaCanada
- TURUN YLIOPISTO · TurkuFinland
- UNIVERSIDADE DE COIMBRA · CoimbraPortugal
- UNIVERSITA DEGLI STUDI DI PADOVA · PadovaItaly
- UNIVERSITA DEGLI STUDI DI SASSARI · SassariItaly
- UNIVERSITE LYON 1 CLAUDE BERNARD · Villeurbanne CedexFrance
- UNIVERSITY OF MIAMI · Coral Gables MiamiUnited States
- UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU · PoznanPoland
- YOURSCIENCEBE · Bruxelles / BrusselBelgium
Links
Data: CORDIS, © European Union